The Oncology Institute, Inc. (TOI)
NASDAQ: TOI · Real-Time Price · USD
3.540
+0.020 (0.57%)
At close: Sep 26, 2025, 4:00 PM EDT
3.630
+0.090 (2.54%)
After-hours: Sep 26, 2025, 7:53 PM EDT
The Oncology Institute Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for The Oncology Institute stock has a target of 6.00, which predicts a 69.49% increase from the current stock price of 3.54.
Price Target: $6.00 (+69.49%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Jul 16, 2025.
Analyst Ratings
According to 1 stock analyst, the rating for The Oncology Institute is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 | Sep '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 1 | 1 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| B. Riley Securities | B. Riley Securities | Strong Buy Initiates $6 | Strong Buy | Initiates | $6 | +69.49% | Jul 16, 2025 |
| Jefferies | Jefferies | Strong Buy Initiates $2.5 | Strong Buy | Initiates | $2.5 | -29.38% | Feb 26, 2024 |
| Guggenheim | Guggenheim | Strong Buy Maintains $3 → $2 | Strong Buy | Maintains | $3 → $2 | -43.50% | Jun 16, 2023 |
| Guggenheim | Guggenheim | Hold Maintains $6 → $3 | Hold | Maintains | $6 → $3 | -15.25% | Mar 20, 2023 |
| Guggenheim | Guggenheim | Strong Buy Maintains $7 → $6 | Strong Buy | Maintains | $7 → $6 | +69.49% | Nov 11, 2022 |
Financial Forecast
Revenue This Year
478.81M
from 393.41M
Increased by 21.71%
Revenue Next Year
577.37M
from 478.81M
Increased by 20.58%
EPS This Year
-0.55
from -0.71
EPS Next Year
-0.28
from -0.55
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 |
|---|---|---|
| High | 499.1M | 611.5M |
| Avg | 478.8M | 577.4M |
| Low | 462.7M | 549.7M |
Revenue Growth
| Revenue Growth | 2025 | 2026 |
|---|---|---|
| High | 26.9% | 27.7% |
| Avg | 21.7% | 20.6% |
| Low | 17.6% | 14.8% |
EPS Forecast
| EPS | 2025 | 2026 |
|---|---|---|
| High | -0.51 | -0.29 |
| Avg | -0.55 | -0.28 |
| Low | -0.59 | -0.27 |
EPS Growth
| EPS Growth | 2025 | 2026 |
|---|---|---|
| High | - | - |
| Avg | - | - |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.